Targeting the Arginine Vasopressin V1b Receptor System and Stress Response in Depression and Other Neuropsychiatric Disorders
Neuropsychiatric Disease and Treatment · 2023-04 · Volume 19 · 811-828
DOI: 10.2147/ndt.s402831 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuropsychiatric Disease and Treatment, 2023-04. Verfasst von Stephen J Kanes und 2 weiteren Autor:innen. Beteiligte Einrichtung: EmbarkNeuro, Oakland, CA, USA. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- EmbarkNeuro, Oakland, CA, USA.
ORCID-Profile: Stephen J Kanes, Lara Dennie, Philip Perera
Zitieren
APA
Kanes, S. J., Dennie, L., & Perera, P. (2023). Targeting the Arginine Vasopressin V1b Receptor System and Stress Response in Depression and Other Neuropsychiatric Disorders. Neuropsychiatric Disease and Treatment, Volume 19, 811-828. https://doi.org/10.2147/ndt.s402831
Vancouver
Kanes SJ, Dennie L, Perera P. Targeting the Arginine Vasopressin V1b Receptor System and Stress Response in Depression and Other Neuropsychiatric Disorders. Neuropsychiatric Disease and Treatment. 2023;Volume 19:811-828. doi:10.2147/ndt.s402831
BibTeX
@article{Kanes2023,
author = {Kanes, Stephen J and Dennie, Lara and Perera, Philip},
title = {Targeting the Arginine Vasopressin V1b Receptor System and Stress Response in Depression and Other Neuropsychiatric Disorders},
journal = {Neuropsychiatric Disease and Treatment},
year = {2023},
volume = {Volume 19},
pages = {811--828},
doi = {10.2147/ndt.s402831}
}
EUVIMED